OpenVSafe by OpenVAERS
Search V-safe

GCG-10072-30483

4 vaccinations 2 coded responses 19 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
662 / KS
Registered
2021-02-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-11
    Registered in v-safe
  3. 2021-02-11
    Dose 2 — Pfizer-BioNTech
  4. 2021-02-11
    Health check-in — day 0, dose 2
    Feeling: Good · Headache, Muscle or body aches
    Adult check-in
  5. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-02-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tiredness
    Free text: Swelling in the lymph node of the armpit on the side I received the injection
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Diarrhea
    Adult check-in
  9. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  11. 2021-02-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-25
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-15
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-08-12
    Survey response — 6 months, dose 2
    MedDRA: Heart rate increased — Feeling: Good
    Free text: Increased resting heart rate
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  19. 2021-12-10
    Dose 3 — Pfizer-BioNTech
  20. 2022-02-11
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2023-04-21
    Dose 4 — Pfizer-BioNTech
  22. 2023-04-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  23. 2023-04-23
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  24. 2023-04-24
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-20Pfizer-BioNTech
22021-02-11Pfizer-BioNTech
32021-12-10Pfizer-BioNTech No
42023-04-21Pfizer-BioNTech No

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-13

Systemic reaction (other): Swelling in the lymph node of the armpit on the side I received the injection

Release 9 — 6 months, dose 2

2021-08-12

Symptoms: Increased resting heart rate

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeart rate increased ✓ · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release